Sponsor Pipeline

AbelZeta Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
0
Recruiting
1
Disease Areas
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-07-28 NCT07729826 C-CAR168 CAR T-Cell Therapy for the Treatment of Lupus Nephritis Refractory to Standard… Phase 2 Not Yet Recruiting
Active Trials by Phase
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07729826 C-CAR168 CAR T-Cell Therapy for the Treatment of Lupus Nephritis Refractory to Standard… Lupus Nephritis (LN) Not Yet Recruiting
Disease Areas
Lupus (SLE) (1)
Get alerts when AbelZeta Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free